Mycobacterial lymphadenitis associated with the initiation of combination antiretroviral therapy

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 20, Issue 2, 1999, Pages 122-128

  Phillips, Peter ^a,b   Kwiatkowski, Margret B ^a   Copland, Michael ^a   Craib, Kevin ^a   Montaner, Julio ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

Author keywords

Antiretroviral therapy; Lymphadenitis; Mycobacterial infection

Indexed keywords

DIDANOSINE; INDINAVIR; LAMIVUDINE; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHADENITIS; LYMPHOCYTE COUNT; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; PRIORITY JOURNAL;

EID: 0033080844     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199902010-00003     Document Type: Article

References (29)

1. Pallela FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-60.
2. Hogg RS, O'Shaughnessy MV, Gataric N, et al. Decline in deaths from AIDS due to new antiretrovirals. Lancet 1997;349:1294.
3. Power C, Nath A, Aoki FY, Del Bigio M. Remission of progressive multifocal leukoencephalopathy following splenectomy and antiretroviral therapy in a patient with HIV infection. N Engl J Med 1997;336;661-2.
4. Mileno MD, Tashima K, Farrar D, Elliot BC, Rich JD, Flanigan TP. Resolution of AIDS-related opportunistic infections with addition of protease inhibitor treatment [abstract 355]. Presented at the 4th Conference on Retroviruses and Opportunistic Infections, Washington, DC, 1997.
5. Henry K, Worley J, Sullivan C, Stawarz K, McCabe K. Documented improvement in late stage manifestations of AIDS after starting ritonavir in combination with two reverse transcriptase inhibitors [abstract 356]. Presented at the 4th Conference on Retroviruses and Opportunistic Infections, Washington, DC, 1997.
6. Benhamou Y, Bouchet MV, Carriere J, et al. Effects of triple antiretroviral therapies including a HIV protease inhibitor on chronic intestinal cryptosporidiosis and microsporidiosis in HIV-infected patients [abstract 357]. Presented at the 4th Conference on Retroviruses and Opportunistic Infections, Washington, DC, 1997.
7. Carr A, Marriott D, Field A, Vasek E, Cooper DA. Treatment of HIV-1 associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy. Lancet 1998;351:256-61.
8. Zingman BS. Resolution of refractory AIDS-related mucosal candidiasis after initiation of didanosine plus saquinavir. N Engl J Med 1996;334:1674-5.
9. Hicks CB, Myers SA, Giner J. Resolution of intractable molluscum contagiosum in a human immunodeficiency virus-infected patient after institution of antiretroviral therapy with ritonavir. Clin Infect Dis 1997;24:1023-5.
10. Jacobsen MA, Zegans M, Pavan PR, et al. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 1997;349:1443-5.
11. Race E, Adelson-Mitty J, Kriegel GR, et al. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor in patients with advanced HIV-1 disease. Lancet 1998;351:252-5.
12. Phillips P, Zala C, Rouleau D, Montaner JSG. Mycobacterial lymphadenitis: can highly active antiretroviral therapy (HAART) unmask subclinical infection [abstract 351]? Presented at the 4th Conference on Retroviruses and Opportunistic Infections, Washington, DC, 1997.
13. French MAH, Mallal SA, Dawkins RL. Zidovudine induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients. AIDS 1992;6:1293-7.
14. Packer SJ, Cesario T, Williams JH Jr. Mycobacterium avium complex infection presenting as endobronchial lesions in immunosuppressed patients. Ann Intern Med 1988;109:389-93.
15. Barbaro DJ, Orcutt VL, Coldiron BM. Mycobacterium avium-Mycobacterium intracellulare infection limited to the skin and lymph nodes in patients with AIDS. Rev Infect Dis 1989:11:625-8.
16. Kent PT, Kubica GP. Public health mycobacteriology: a guide for the level III laboratory. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control, 1985:PB86-21654-6.
17. Michelet C, Arvieux C, Aubert V, Andre P, Riou A, Cartier F. Viral ocular involvement after initiation of antiprotease inhibitor therapy [abstract 315]. Presented at the 4th Conference on Retroviruses and Opportunistic Infections, Washington, DC, 1997.
18. Gilquin J, Piketty C, Thomas V, Gonzales-Canali G, Kazatchkine MD. Acute CMV infection in AIDS patients receiving combination therapy including protease inhibitors [abstract 354]. Presented at the 4th Conference on Retroviruses and Opportunistic Infections, Washington, DC, 1997 .
19. Mallal SA, James IR, French MAH. Detection of subclinical Mycobacterium avium intracellulare complex infection in immunodeficient HIV-infected patients treated with zidovudine. AIDS 1994;8:1263-9.
20. Chloremis CB, Padiatellis C, Zoumboulakis D, Yannakos D. Transitory exacerbation of fever and roentgenographic findings during treatment of tuberculosis in children. Am Rev Tuberculosis 1955; 72:527-36.
21. Narita M, Ashkin D, Hullender ES, Pitchenik AE. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med 1998;158:157-61.
22. Bottaro E, Elsner B, Cassetti Y. Histoplasmosis y HAART: aparicion de adenomegalias durante el tratamiento [abstract B1-101]. Presented at the 3rd Argentinean Congress on AIDS, Mar del Plata, 1997.
23. Sansonetti P, Lagrange PH. The immunology of leprosy: speculations on the leprosy spectrum. Rev Infect Dis 1981;3:422-69.
24. Van Voorhis WC, Kaplan G, Nunes Sarno E, et al. The cutaneous infiltrates of leprosy: cellular characteristics and the predominant T-cell phenotypes. N Engl J Med 1982;307:1593-7.
25. Benson CA, Ellner JJ. Mycobacterium avium complex infection and AIDS: advances in theory and practice, Clin Infect Dis 1993; 17:7-20.
26. Schaad UB, Votteler TP, McCracken GH Jr, Nelson JD. Management of atypical mycobacterial lymphadenitis in childhood: a review based on 380 cases. Pediatrics 1979;95:356-60.
27. Yarchoan R, Klecker RW, Weinhold KJ, et al. Administration of 3′-azido-3′-deoxythymidine, an inhibitor of HTLV III/LAV replication to patients with AIDS and AIDS-related complex. Lancet 1986;1:575-80.
28. Di Perri G, Bonora S, Vento S, Allegranzi B, Concia E. Highly active antiretroviral therapy (C). Lancet 1998;351:1056.
29. U.S. Public Health Service (USPHS)/Infectious Disease Society of America (IDSA) Prevention of Opportunistic Infections Working Group. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWR Morb Mortal WkLy Rep 1997:46(RR-12).